NCT00705471View on ClinicalTrials.gov

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

TerminatedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Crohn Disease
Interventions
BIOLOGICAL

Infliximab

None available in the protocol. This was a chart review study, therefore no Infliximab provided during the study.

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY